Read & share
Visual library
Research and clinical ideas, distilled into original infographics.
Explore the collection ↗Evidence-based obesity medicineObesity medicine,
Created byJoseph Zucchi, PA-C, MPASPhysician Associate · Obesity medicine
Obesity medicine,
explained visually.
Original infographics and interactive explanations of obesity treatments, research, and patient care.
Created byJoseph Zucchi, PA-C, MPASPhysician Associate · Obesity medicineNEW IN THE LIBRARY
The Next Wave of Obesity Medicine: 12 Investigational Therapies
A November 2026 overview of 12 investigational obesity therapies, spanning amylin-based treatments, GLP-1/GIP pathways, glucagon-containing combinations, and GLP-1 receptor agonists.
For clinicians, patients, educators, and anyone interested in obesity medicine.
Phase 2Phase 3
Follow development
Therapy pipeline
Explore 47 pipeline profiles, their studies, and next development steps.
Explore the pipeline ↗250 lb example start225 lb
Use in the clinic
Clinical tools
Turn numbers into visual explanations for clinical conversations.
Open the tools ↗See everything in one place
Explore All Resources ↗Find your next resource
Browse the full guide to visuals, interactive science, treatments, and clinical tools.
More from the library
All recent visuals ↗Latest from Joe
Advancing Beyond Weight Loss: AHA Scientific Sessions 2026
Three obesity medication findings from AHA Scientific Sessions 2026: survodutide and cardiovascular safety, orforglipron and sleep apnea, and semaglutide and obesity-related heart failure.
Health Outcomes
Get to Know VK2735
A six-slide overview of VK2735, covering injectable and oral Phase 2 results, exploratory maintenance dosing, dose-specific tolerability and Phase 3 programs.
Clinical Trials & Pipeline
Retatrutide vs Semaglutide 2 mg
A visual summary of sponsor-reported 80-week Phase 3 TRANSCEND-T2D-2 results comparing retatrutide with semaglutide 2 mg in adults with type 2 diabetes.
Clinical Trials & Pipeline
Explore the science
Explore how hormones shape appetite, digestion and metabolism.
Choose a hormone and body area to see what we know and what researchers are still studying.
Why Obesity Is a Chronic Disease
See how biology, environment, and support influence weight.
Explore the visual guide ↗FDA-approved obesity medicinesApproved obesity medicines
Compare FDA label uses and the trials behind them.
View approved medicines ↗Beyond the infographic
View All Articles & Media ↗Articles, Podcasts & Talks
The Obesity-Liver Connection
AAPA Vital Rounds · Four-part video series
A practical series covering obesity’s effects across organ systems, MASLD and MASH, fibrosis assessment, treatment approaches, and respectful obesity care.
The Multifaceted Impact of Obesity: A Comprehensive Path to Management
APP Obesity Summit · Dallas
Keynote presentation at the APP Obesity Summit in Dallas, exploring obesity’s multisystem effects and a comprehensive approach to care.
GLP-1s Explained: The Facts, Fiction, and What's Next
The Good Clean Nutrition Podcast
Sponsored by Orgain
About Joe
I’m a physician associate practicing obesity medicine in New Hampshire. I make these visuals to explain the research, answer common questions, and share what I’m learning with other clinicians. I also serve on the board of the New England Obesity Society, speak nationally about obesity medicine, and advocate for better coverage and access to treatment. In 2026, I was honored to receive POCN’s America’s Top PA award.